Steven Cohen's DXCM Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.22 M shares of DexCom, Inc. (DXCM) worth $80.81 M, representing 0.09% of the portfolio. First purchased in 2015-Q4, this long-term strategic position has been held for 35 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in DXCM, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2018, adding 3.52 M shares. Largest reduction occurred in Q3 2018, reducing 3.08 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's DexCom (DXCM) Holding Value Over Time
Track share changes against reported price movement
Quarterly DexCom (DXCM) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1.02 M | Reduce 45.54% | 1.22 M | $66.37 |
| Q3 2025 | +2.24 M | New Buy | 2.24 M | $67.29 |
| Q2 2025 | -386,904 | Sold Out | 0 | $0.00 |
| Q1 2025 | -1.21 M | Reduce 75.80% | 386,904 | $68.29 |
| Q4 2024 | +1.6 M | New Buy | 1.6 M | $77.77 |
| Q4 2023 | -813,058 | Sold Out | 0 | $0.00 |
| Q3 2023 | +792,140 | Add 3786.88% | 813,058 | $93.30 |
| Q2 2023 | -1.54 M | Reduce 98.66% | 20,918 | $128.51 |
| Q1 2023 | +1.36 M | Add 670.08% | 1.56 M | $116.18 |
| Q4 2022 | -627,528 | Reduce 75.57% | 202,835 | $113.24 |
| Q3 2022 | -78,446 | Reduce 8.63% | 830,363 | $80.54 |
| Q2 2022 | +908,809 | New Buy | 908,809 | $74.53 |
| Q2 2021 | -128,000 | Sold Out | 0 | $0.00 |
| Q1 2021 | -678,400 | Reduce 84.13% | 128,000 | $89.84 |
| Q4 2020 | +205,140 | Add 34.12% | 806,400 | $92.43 |
| Q3 2020 | +541,260 | Add 902.10% | 601,260 | $103.06 |
| Q2 2020 | +12,812 | Add 27.15% | 60,000 | $101.35 |
| Q1 2020 | -432,668 | Reduce 90.17% | 47,188 | $67.33 |
| Q4 2019 | -430,184 | Reduce 47.27% | 479,856 | $54.69 |
| Q3 2019 | -280,548 | Reduce 23.56% | 910,040 | $37.31 |
| Q2 2019 | +514,260 | Add 76.04% | 1.19 M | $37.46 |
| Q1 2019 | +418,672 | Add 162.49% | 676,328 | $29.78 |
| Q4 2018 | -1.56 M | Reduce 85.82% | 257,656 | $29.95 |
| Q3 2018 | -3.08 M | Reduce 62.94% | 1.82 M | $35.76 |
| Q2 2018 | +984,676 | Add 25.14% | 4.9 M | $23.74 |
| Q1 2018 | +3.52 M | Add 879.18% | 3.92 M | $18.54 |
| Q4 2017 | -120,000 | Reduce 23.08% | 400,000 | $14.35 |
| Q3 2017 | -978,264 | Reduce 65.29% | 520,000 | $12.23 |
| Q2 2017 | +1.32 M | Add 738.76% | 1.5 M | $18.29 |
| Q1 2017 | -591,772 | Reduce 76.81% | 178,628 | $21.18 |
| Q4 2016 | +36,000 | Add 4.90% | 770,400 | $14.92 |
| Q3 2016 | -309,600 | Reduce 29.66% | 734,400 | $21.91 |
| Q2 2016 | +12,400 | Add 1.20% | 1.04 M | $19.83 |
| Q1 2016 | +132,800 | Add 14.78% | 1.03 M | $16.98 |
| Q4 2015 | +898,800 | New Buy | 898,800 | $20.48 |
Steven Cohen's DexCom Investment FAQs
Steven Cohen first purchased DexCom, Inc. (DXCM) in Q4 2015, acquiring 898,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held DexCom, Inc. (DXCM) for 35 quarters since Q4 2015.
Steven Cohen's largest addition to DexCom, Inc. (DXCM) was in Q1 2018, adding 3,916,700 shares worth $72.62 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,217,607 shares of DexCom, Inc. (DXCM), valued at approximately $80.81 M.
As of the Q4 2025 filing, DexCom, Inc. (DXCM) represents approximately 0.09% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in DexCom, Inc. (DXCM) was 4,901,376 shares, as reported at the end of Q2 2018.